Zhi Nan, Ren Rujing, Qi Jinlei, Liu Xinya, Yun Zike, Lin Shaohui, Hu Yisong, Li Haixia, Xie Xinyi, Wang Jintao, Li Jianping, Zhu Yikang, Gao Mengyi, Yang Junjie, Wang Yiran, Jing Yurong, Geng Jieli, Cao Wenwei, Xu Qun, Yu Xiaoping, Zhu Yuan, Zhou Ying, Wang Lin, Gao Chao, Li Binyin, Chen Shengdi, Yuan Fang, Dou Ronghua, Liu Xiaoyun, Li Xuena, Yin Yafu, Chang Yan, Xu Gang, Zhong Yanting, Li Chunbo, Wang Ying, Zhou Maigeng, Wang Gang
Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gen Psychiatr. 2025 Aug 7;38(4):e102020. doi: 10.1136/gpsych-2024-102020. eCollection 2025.
With the sustained growth of the economy and significant changes in social demographics, the issue of elderly-related diseases has increasingly drawn attention, particularly. Alzheimer's disease (AD), as a representative disease of neurodegenerative diseases, has become a major challenge, affecting the health and quality of life of the elderly population severely. In recent years, the incidence, prevalence and mortality rates of AD have increased in China, imposing substantial economic burdens on families, society and the entire healthcare system. To proactively address this challenge and respond to the national 'Healthy China Action' initiative, leading experts from authoritative institutions jointly authored the China Alzheimer Report 2025. Building on previous editions, this report updates epidemiological data on AD in China, thoroughly analyses the latest economic burdens of the disease and comprehensively evaluates the current status of AD diagnosis and treatment services, as well as the allocation of public health resources in our country. Its release reflects China's progress in AD research and prevention, underscores societal concern for elderly health and aims to provide scientific guidance and data support for AD prevention, diagnosis and treatment. It also facilitates academic exchanges and cooperation, enhancing public awareness and promoting active participation in elderly healthcare, towards achieving 'healthy ageing' in China.
随着经济的持续增长和社会人口结构的显著变化，与老年人相关的疾病问题日益受到关注，尤其是阿尔茨海默病（AD），作为神经退行性疾病的代表性疾病，已成为一项重大挑战，严重影响老年人群的健康和生活质量。近年来，中国AD的发病率、患病率和死亡率均有所上升，给家庭、社会和整个医疗体系带来了沉重的经济负担。为积极应对这一挑战并响应国家“健康中国行动”倡议，权威机构的顶尖专家共同撰写了《中国阿尔茨海默病报告2025》。本报告在以往版本的基础上，更新了中国AD的流行病学数据，深入分析了该疾病最新的经济负担，并全面评估了我国AD诊断和治疗服务的现状以及公共卫生资源的配置情况。其发布反映了中国在AD研究与预防方面的进展，凸显了社会对老年人健康的关注，旨在为AD的预防、诊断和治疗提供科学指导与数据支持。它还促进了学术交流与合作，提高公众意识并推动积极参与老年保健，以实现中国的“健康老龄化”。
